Medicare Enrolled
Dr. John Kailath, M.D.
Hematology & Oncology · Carmichael, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kailath from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kailath?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kailath
Dr. John Kailath is a hematology & oncology specialist in Carmichael, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kailath performed 70,986 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kailath received a total of $7,942 from 55 pharmaceutical and/or device companies across 323 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kailath is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 11% volume in CA
$7,942 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗70,986
Medicare services
Top 11% in CA for hematology & oncology
Not available
Unique patients (not deduplicated)
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
42,330 | $0 | $3 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
10,950 | $0 | $3 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
4,910 | $6 | $24 |
| Anti-nausea injection (ondansetron/Zofran) | 3,192 | $0 | $0 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,650 | $0 | $0 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,178 | $8 | $22 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
914 | $7 | $7 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
614 | $71 | $198 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
613 | $104 | $287 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
417 | $10 | $29 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
360 | $2 | $7 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
319 | $25 | $83 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
295 | $14 | $44 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
292 | $116 | $379 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
271 | $12 | $38 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
193 | $41 | $102 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
178 | $55 | $191 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
132 | $57 | $184 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
132 | $7 | $28 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
129 | $0 | $2 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
101 | $17 | $56 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
93 | $1 | $2 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
91 | $1 | $3 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
86 | $11 | $36 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
78 | $25 | $81 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
70 | $19 | $62 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
70 | $1 | $4 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
68 | $30 | $85 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
51 | $130 | $431 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
37 | $66 | $189 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
36 | $144 | $527 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
33 | $74 | $274 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
31 | $108 | $358 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
30 | $28 | $92 |
| New patient office visit, complex (60-74 min) | 23 | $162 | $544 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
19 | $33 | $106 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
61.4% high complexity
32.5% medium
6.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,942
Total received (2018-2024)
Avg $1,135/year across 7 years
Top 35% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
323
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,186
2023
$1,147
2022
$1,876
2021
$2,030
2020
$218
2019
$820
2018
$666
Payments by company (2024)
Astellas Pharma US Inc
$174
Tempus AI, Inc
$161
PFIZER INC.
$144
Novartis Pharmaceuticals Corporation
$143
Incyte Corporation
$84
GlaxoSmithKline, LLC.
$70
Merck Sharp & Dohme LLC
$49
Daiichi Sankyo Inc.
$42
E.R. Squibb & Sons, L.L.C.
$39
Celgene Corporation
$35
ARRAY BIOPHARMA INC
$34
SpringWorks Therapeutics, Inc.
$30
Agios Pharmaceuticals, Inc.
$26
ABBVIE INC.
$25
AstraZeneca Pharmaceuticals LP
$24
Regeneron Healthcare Solutions, Inc.
$24
Genmab U.S., Inc.
$23
Genentech USA, Inc.
$20
SERVIER PHARMACEUTICALS LLC
$20
Gilead Sciences, Inc.
$18
Top 3 companies account for 40.4% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$937
US Oncology Corporate, Inc.
$842
Janssen Biotech, Inc.
$720
Astellas Pharma US Inc
$534
Amgen Inc.
$509
E.R. Squibb & Sons, L.L.C.
$461
Novartis Pharmaceuticals Corporation
$363
Seagen Inc.
$289
Kite Pharma, Inc.
$234
Genentech USA, Inc.
$233
Incyte Corporation
$184
GlaxoSmithKline, LLC.
$171
Tempus AI, Inc
$161
TerSera Therapeutics LLC
$152
Gilead Sciences, Inc.
$148
Lilly USA, LLC
$137
Pharmacyclics LLC, An AbbVie Company
$133
AstraZeneca Pharmaceuticals LP
$129
AbbVie, Inc.
$122
Celgene Corporation
$121
Daiichi Sankyo Inc.
$104
SANOFI-AVENTIS U.S. LLC
$100
Merck Sharp & Dohme LLC
$93
SERVIER PHARMACEUTICALS LLC
$88
Merck Sharp & Dohme Corporation
$85
ARRAY BIOPHARMA INC
$80
Exelixis Inc.
$70
ABBVIE INC.
$66
Regeneron Healthcare Solutions, Inc.
$49
Sumitomo Pharma America, Inc.
$47
Acrotech Biopharma LLC
$41
Myovant Sciences Inc.
$40
EMD Serono, Inc.
$39
Deciphera Pharmaceuticals Inc.
$38
BeiGene USA, Inc.
$37
Pharmacyclics LLC, an AbbVie Company
$31
SpringWorks Therapeutics, Inc.
$30
Agios Pharmaceuticals, Inc.
$26
UIH Solutions LLC
$25
Eisai Inc.
$24
Genmab U.S., Inc.
$23
Foundation Medicine, Inc.
$22
Alexion Pharmaceuticals, Inc.
$21
PUMA BIOTECHNOLOGY, INC.
$20
GENZYME CORPORATION
$19
CTI BioPharma Corp.
$19
EISAI INC.
$18
APO-PHARMA USA, INC.
$17
AMAG Pharmaceuticals, Inc.
$16
Sirtex Medical Inc
$16
Organon LLC
$15
Puma Biotechnology, Inc.
$13
Jazz Pharmaceuticals Inc.
$13
Bayer HealthCare Pharmaceuticals Inc.
$12
Janssen Pharmaceuticals, Inc
$8
Top 3 companies account for 31.5% of all-time payments
Associated products mentioned in payments ›
Alecensa · Aranesp · Avastin · BELEODAQ · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · DARZALEX · DEFERIPRONE · ELIQUIS · ELITEK · EPKINLY · ERLEADA · Enhertu · Epkinly · Erleada · FERAHEME · Fabhalta · GAZYVA · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · Imbruvica · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUPRON DEPOT · LYNPARZA · Lenvima · MARQIBO · MEKINIST · MYLOTARG · NERLYNX · Nerlynx · Nplate · OGSIVEO · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Perjeta · Pomalyst · QINLOCK · Quzyttir · REBLOZYL · RYBREVANT · Revlimid · SCEMBLIX · SIR-Spheres Microspheres · SPRYCEL · SUTENT · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TUKYSA · Tibsovo · Trodelvy · ULTOMIRIS · VERZENIO · Vonjo · XALKORI · XT CDX · XTANDI · Xermelo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · Zoladex · uMR 570
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
82
County median income
$88,724
Nearest hospital to ZIP centroid (approximate)
MERCY SAN JUAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kailath is a mixed practice specialist, with above-average Medicare volume (top 11% in CA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kailath experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Kailath performed 42,330 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kailath receive payments from pharmaceutical companies?
Yes. Dr. Kailath received a total of $7,942 from 55 companies across 323 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kailath's costs compare to other hematology & oncology specialists in Carmichael?
Dr. Kailath's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kailath) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Carmichael
Browse hematology & oncology specialists in Carmichael ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
US Oncology Corporate, Inc. Payments to Doctors
See all physicians who received payments from US Oncology Corporate, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology